Similar articles for PMID: 24712891

Year	Number of Results
1971	1
1984	1
1997	1
2002	2
2003	1
2004	2
2005	2
2006	4
2007	6
2008	12
2009	13
2010	10
2011	12
2012	13
2013	12
2014	9
2015	11
2016	19
2017	4
2018	3
2019	5
2020	3
2021	5
2022	2
2024	0

1

Considerations in individualizing prophylaxis in patients with haemophilia A.

Valentino LA. Valentino LA. Haemophilia. 2014 Sep;20(5):607-15. doi: 10.1111/hae.12438. Epub 2014 Apr 8. Haemophilia. 2014. PMID: 24712891 Review.

2

Personalized prophylaxis.

Collins PW. Collins PW. Haemophilia. 2012 Jul;18 Suppl 4:131-5. doi: 10.1111/j.1365-2516.2012.02838.x. Haemophilia. 2012. PMID: 22726096

3

Comparing prophylaxis with episodic treatment in haemophilia A: implications for clinical practice.

Manco-Johnson M. Manco-Johnson M. Haemophilia. 2007 Sep;13 Suppl 2:4-9. doi: 10.1111/j.1365-2516.2007.01499.x. Haemophilia. 2007. PMID: 17685917 Clinical Trial.

4

Secondary prophylaxis in an adult patient with severe haemophilia A. Factor VIII consumption and effectiveness.

Schlenkrich S, Schubert C. Schlenkrich S, et al. Hamostaseologie. 2013 Aug 1;33(3):241-4. doi: 10.5482/HAMO-12-07-0013. Epub 2013 Feb 25. Hamostaseologie. 2013. PMID: 23435748

5

Short-term low-dose secondary prophylaxis for severe/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle in its execution: a multi-centre pilot study in China.

Tang L, Wu R, Sun J, Zhang X, Feng X, Zhang X, Luke KH, Poon MC. Tang L, et al. Haemophilia. 2013 Jan;19(1):27-34. doi: 10.1111/j.1365-2516.2012.02926.x. Haemophilia. 2013. PMID: 23231016

6

Current prescription of prophylactic factor infusions and perceived adherence for children and adolescents with haemophilia: a survey of haemophilia healthcare professionals in the United States.

Thornburg CD, Carpenter S, Zappa S, Munn J, Leissinger C. Thornburg CD, et al. Haemophilia. 2012 Jul;18(4):568-74. doi: 10.1111/j.1365-2516.2012.02756.x. Epub 2012 Feb 15. Haemophilia. 2012. PMID: 22335526 Free article.

7

Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.

Schobess R, Kurnik K, Friedrichs F, Halimeh S, Krümpel A, Bidlingmaier C, Nowak-Göttl U. Schobess R, et al. Thromb Haemost. 2008 Jan;99(1):71-6. doi: 10.1160/TH07-06-0417. Thromb Haemost. 2008. PMID: 18217137

8

Prevention of arthropathy in haemophilia: prophylaxis.

Santagostino E, Mancuso ME. Santagostino E, et al. Haemophilia. 2008 Nov;14 Suppl 6:16-9. doi: 10.1111/j.1365-2516.2008.01884.x. Haemophilia. 2008. PMID: 19134028

9

Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A.

Young G, Mahlangu J, Kulkarni R, Nolan B, Liesner R, Pasi J, Barnes C, Neelakantan S, Gambino G, Cristiano LM, Pierce GF, Allen G. Young G, et al. J Thromb Haemost. 2015 Jun;13(6):967-77. doi: 10.1111/jth.12911. Epub 2015 Apr 23. J Thromb Haemost. 2015. PMID: 25912075 Free article. Clinical Trial.

10

Rationale for individualizing haemophilia care.

Sørensen B, Auerswald G, Benson G, Elezović I, Felder M, Lambert T, Morfini M, Remor E, Salaj P, Santagostino E, Šalek SZ, Ljung R. Sørensen B, et al. Blood Coagul Fibrinolysis. 2015 Dec;26(8):849-57. doi: 10.1097/MBC.0000000000000225. Blood Coagul Fibrinolysis. 2015. PMID: 25396764 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

131 results

Results by year